Canopy Growth (CGC) EBIT (QoQ) (2019 - 2025)
Canopy Growth (CGC) EBIT (QoQ) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -284.77% |
| Sep 30, 2025 | 24.82% |
| Dec 31, 2024 | 49.37% |
| Sep 30, 2024 | -58.25% |
| Jun 30, 2024 | 73.13% |
| Mar 31, 2024 | -78.79% |
| Dec 31, 2023 | -747.65% |
| Sep 30, 2023 | 87.15% |
| Jun 30, 2023 | 89.90% |
| Mar 31, 2023 | -385.39% |
| Dec 31, 2022 | 27.42% |
| Sep 30, 2022 | 92.09% |
| Jun 30, 2022 | -292.99% |
| Mar 31, 2022 | -209.08% |
| Dec 31, 2021 | 30.46% |
| Sep 30, 2021 | -12.03% |
| Jun 30, 2021 | 17.12% |
| Mar 31, 2021 | 56.61% |
| Dec 31, 2020 | -99.07% |
| Sep 30, 2020 | -71.59% |